Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Guzmán CA[au]:

Self-Replicating RNA Vaccine Delivery to Dendritic Cells. Démoulins T et al. Methods Mol Biol. (2017)

Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions. Börger AK et al. Mol Med. (2016)

In Silico Vaccine Strain Prediction for Human Influenza Viruses. Klingen TR et al. Trends Microbiol. (2018)

Search results

Items: 1 to 50 of 277

1.

Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge.

Zheng X, Oduro JD, Boehme JD, Borkner L, Ebensen T, Heise U, Gereke M, Pils MC, Krmpotic A, Guzmán CA, Bruder D, Čičin-Šain L.

PLoS Pathog. 2019 Sep 16;15(9):e1008036. doi: 10.1371/journal.ppat.1008036. [Epub ahead of print]

2.

In vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infection.

Sharma-Chawla N, Stegemann-Koniszewski S, Christen H, Boehme JD, Kershaw O, Schreiber J, Guzmán CA, Bruder D, Hernandez-Vargas EA.

Front Immunol. 2019 Aug 14;10:1864. doi: 10.3389/fimmu.2019.01864. eCollection 2019.

3.

Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine.

Perche F, Clemençon R, Schulze K, Ebensen T, Guzmán CA, Pichon C.

Mol Ther Nucleic Acids. 2019 Sep 6;17:767-775. doi: 10.1016/j.omtn.2019.07.014. Epub 2019 Jul 30.

4.

Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune Intervention.

Trittel S, Vashist N, Ebensen T, Chambers BJ, Guzmán CA, Riese P.

Front Immunol. 2019 Aug 7;10:1849. doi: 10.3389/fimmu.2019.01849. eCollection 2019.

5.

Self-reported diabetes and herpes zoster are associated with a weak humoral response to the seasonal influenza A H1N1 vaccine antigen among the elderly.

Akmatov MK, Riese P, Trittel S, May M, Prokein J, Illig T, Schindler C, Guzmán CA, Pessler F.

BMC Infect Dis. 2019 Jul 23;19(1):656. doi: 10.1186/s12879-019-4214-x.

6.

The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.

Volckmar J, Knop L, Stegemann-Koniszewski S, Schulze K, Ebensen T, Guzmán CA, Bruder D.

Vaccine. 2019 Aug 14;37(35):4963-4974. doi: 10.1016/j.vaccine.2019.07.019. Epub 2019 Jul 15.

7.

Novel colloidal associations of soyasaponins and lipid components (DPPC, cholesterol) as potential adjuvants for vaccines.

de Groot C, Müsken M, Bleckmann M, Ebensen T, Guzmán CA, Müller-Goymann CC.

Vaccine. 2019 Aug 14;37(35):4975-4986. doi: 10.1016/j.vaccine.2019.07.020. Epub 2019 Jul 15.

PMID:
31320217
8.

Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins.

Matthijs AMF, Auray G, Jakob V, García-Nicolás O, Braun RO, Keller I, Bruggman R, Devriendt B, Boyen F, Guzman CA, Michiels A, Haesebrouck F, Collin N, Barnier-Quer C, Maes D, Summerfield A.

Front Immunol. 2019 May 24;10:1087. doi: 10.3389/fimmu.2019.01087. eCollection 2019.

9.

Cohort profile: The LoewenKIDS Study - life-course perspective on infections, the microbiome and the development of the immune system in early childhood.

Gottschick C, Raupach-Rosin H, Langer S, Hassan L, Horn J, Dorendorf E, Caputo M, Bittner M, Beier L, Rübsamen N, Schlinkmann K, Zoch B, Guzman CA, Hansen G, Heselich V, Holzapfel E, Hübner J, Pietschmann T, Pieper DH, Pletz M, Riese P, Schmidt-Pokrzywniak A, Hartwig S, von Kaisenberg C, Aydogdu M, Buhles M, Dressler F, Eberl W, Haase R, von Koch FE, Feidicker S, Frambach T, Franz HGB, Guthmann F, Koch HG, Seeger S, Oberhoff C, Pauker W, Petry KU, Schild RL, Tchirikov M, Röhrig E, Karch A, Mikolajczyk R.

Int J Epidemiol. 2019 Apr 1. pii: dyz069. doi: 10.1093/ije/dyz069. [Epub ahead of print] No abstract available.

PMID:
30938437
10.

The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization.

Ebensen T, Delandre S, Prochnow B, Guzmán CA, Schulze K.

Front Cell Infect Microbiol. 2019 Feb 19;9:31. doi: 10.3389/fcimb.2019.00031. eCollection 2019.

11.

Cohort profile: The LoewenKIDS Study - life-course perspective on infections, the microbiome and the development of the immune system in early childhood.

Gottschick C, Raupach-Rosin H, Langer S, Hassan L, Horn J, Dorendorf E, Caputo M, Bittner M, Beier L, Rübsamen N, Schlinkmann K, Zoch B, Guzman CA, Hansen G, Heselich V, Holzapfel E, Hübner J, Pietschmann T, Pieper DH, Pletz M, Riese P, Schmidt-Pokrzywniak A, Hartwig S, von Kaisenberg C, Aydogdu M, Buhles M, Dressler F, Eberl W, Haase R, Edler von Koch F, Feidicker S, Frambach T, Franz HGB, Guthmann F, Koch HG, Seeger S, Oberhoff C, Pauker W, Petry KU, Schild RL, Tchirikov M, Röhrig E, Mikolajczyk R.

Int J Epidemiol. 2019 Feb 27. pii: dyz001. doi: 10.1093/ije/dyz001. [Epub ahead of print] No abstract available.

PMID:
30815674
12.

Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells.

Theobald SJ, Khailaie S, Meyer-Hermann M, Volk V, Olbrich H, Danisch S, Gerasch L, Schneider A, Sinzger C, Schaudien D, Lienenklaus S, Riese P, Guzman CA, Figueiredo C, von Kaisenberg C, Spineli LM, Glaesener S, Meyer-Bahlburg A, Ganser A, Schmitt M, Mach M, Messerle M, Stripecke R.

Front Immunol. 2018 Nov 22;9:2734. doi: 10.3389/fimmu.2018.02734. eCollection 2018.

13.

Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.

Khera T, Behrendt P, Bankwitz D, Brown RJP, Todt D, Doepke M, Khan AG, Schulze K, Law J, Logan M, Hockman D, Wong JAJ, Dold L, Gonzalez-Motos V, Spengler U, Viejo-Borbolla A, Ströh LJ, Krey T, Tarr AW, Steinmann E, Manns MP, Klein F, Guzman CA, Marcotrigiano J, Houghton M, Pietschmann T.

J Hepatol. 2019 Apr;70(4):593-602. doi: 10.1016/j.jhep.2018.11.003. Epub 2018 Nov 13.

PMID:
30439392
14.

Respiratory Bordetella bronchiseptica Carriage is Associated with Broad Phenotypic Alterations of Peripheral CD4⁺CD25⁺ T Cells and Differentially Affects Immune Responses to Secondary Non-Infectious and Infectious Stimuli in Mice.

Jeron A, Boehme JD, Volckmar J, Gereke M, Yevsa T, Geffers R, Guzmán CA, Schreiber J, Stegemann-Koniszewski S, Bruder D.

Int J Mol Sci. 2018 Sep 1;19(9). pii: E2602. doi: 10.3390/ijms19092602.

15.

Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids.

Englezou PC, Sapet C, Démoulins T, Milona P, Ebensen T, Schulze K, Guzman CA, Poulhes F, Zelphati O, Ruggli N, McCullough KC.

Mol Ther Nucleic Acids. 2018 Sep 7;12:118-134. doi: 10.1016/j.omtn.2018.04.019. Epub 2018 May 4.

16.

Mannose Metabolism Is Essential for Th1 Cell Differentiation and IFN-γ Production.

Zygmunt BM, Węgrzyn A, Gajska W, Yevsa T, Chodaczek G, Guzmán CA.

J Immunol. 2018 Sep 1;201(5):1400-1411. doi: 10.4049/jimmunol.1700042. Epub 2018 Jul 20.

17.

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development.

Lirussi D, Ebensen T, Schulze K, Reinhard E, Trittel S, Riese P, Prochnow B, Guzmán CA.

J Vis Exp. 2018 Jun 19;(136). doi: 10.3791/57401.

PMID:
29985310
18.

Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors.

Eicke D, Baigger A, Schulze K, Latham SL, Halloin C, Zweigerdt R, Guzman CA, Blasczyk R, Figueiredo C.

Sci Rep. 2018 Jul 5;8(1):10146. doi: 10.1038/s41598-018-28459-x.

19.

Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression.

Vashist N, Trittel S, Ebensen T, Chambers BJ, Guzmán CA, Riese P.

Front Immunol. 2018 Mar 22;9:505. doi: 10.3389/fimmu.2018.00505. eCollection 2018.

20.

Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation via Toll-Like Receptor 7.

Stegemann-Koniszewski S, Behrens S, Boehme JD, Hochnadel I, Riese P, Guzmán CA, Kröger A, Schreiber J, Gunzer M, Bruder D.

Front Immunol. 2018 Feb 13;9:245. doi: 10.3389/fimmu.2018.00245. eCollection 2018.

21.

Dual dye in-vivo imaging of differentially charged PLGA carriers reveals antigen-depot effect, leading to improved immune responses in preclinical models.

Riehl M, Harms M, Lucas H, Ebensen T, Guzmán CA, Mäder K.

Eur J Pharm Sci. 2018 May 30;117:88-97. doi: 10.1016/j.ejps.2018.01.040. Epub 2018 Feb 13.

PMID:
29408551
22.

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection.

Sanchez Alberti A, Bivona AE, Cerny N, Schulze K, Weißmann S, Ebensen T, Morales C, Padilla AM, Cazorla SI, Tarleton RL, Guzmán CA, Malchiodi EL.

NPJ Vaccines. 2017 Apr 10;2:9. doi: 10.1038/s41541-017-0010-z. eCollection 2017.

23.

Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes.

Landi A, Law J, Hockman D, Logan M, Crawford K, Chen C, Kundu J, Ebensen T, Guzman CA, Deschatelets L, Krishnan L, Tyrrell DLJ, Houghton M.

Vaccine. 2017 Dec 15;35(50):6949-6956. doi: 10.1016/j.vaccine.2017.10.072. Epub 2017 Oct 28.

PMID:
29089195
24.

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice.

Ebensen T, Debarry J, Pedersen GK, Blazejewska P, Weissmann S, Schulze K, McCullough KC, Cox RJ, Guzmán CA.

Front Immunol. 2017 Sep 28;8:1223. doi: 10.3389/fimmu.2017.01223. eCollection 2017.

25.

In Silico Vaccine Strain Prediction for Human Influenza Viruses.

Klingen TR, Reimering S, Guzmán CA, McHardy AC.

Trends Microbiol. 2018 Feb;26(2):119-131. doi: 10.1016/j.tim.2017.09.001. Epub 2017 Oct 9. Review.

PMID:
29032900
26.

Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure.

Démoulins T, Ebensen T, Schulze K, Englezou PC, Pelliccia M, Guzmán CA, Ruggli N, McCullough KC.

J Control Release. 2017 Nov 28;266:256-271. doi: 10.1016/j.jconrel.2017.09.018. Epub 2017 Sep 19.

PMID:
28935594
27.

Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection.

Schulze K, Ebensen T, Chandrudu S, Skwarczynski M, Toth I, Olive C, Guzman CA.

Nanomedicine. 2017 Nov;13(8):2463-2474. doi: 10.1016/j.nano.2017.08.015. Epub 2017 Sep 5.

PMID:
28887213
28.

Roads to advanced vaccines: influenza case study.

Riese P, Guzmán CA.

Microb Biotechnol. 2017 Sep;10(5):1036-1040. doi: 10.1111/1751-7915.12835. Epub 2017 Aug 15.

29.

Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway.

Lirussi D, Ebensen T, Schulze K, Trittel S, Duran V, Liebich I, Kalinke U, Guzmán CA.

EBioMedicine. 2017 Aug;22:100-111. doi: 10.1016/j.ebiom.2017.07.016. Epub 2017 Jul 19.

30.

Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.

Mazzuca P, Marsico S, Schulze K, Mitola S, Pils MC, Giagulli C, Guzman CA, Caruso A, Caccuri F.

J Virol. 2017 Jul 27;91(16). pii: e00801-17. doi: 10.1128/JVI.00801-17. Print 2017 Aug 15.

31.

Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.

Akmatov MK, Röber N, Ahrens W, Flesch-Janys D, Fricke J, Greiser H, Günther K, Kaaks R, Kemmling Y, Krone B, Linseisen J, Meisinger C, Moebus S, Obi N, Guzman CA, Conrad K, Pessler F.

Arthritis Res Ther. 2017 Jun 6;19(1):127. doi: 10.1186/s13075-017-1338-5.

32.

Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice.

Schulze K, Ebensen T, Babiuk LA, Gerdts V, Guzman CA.

Nanomedicine. 2017 Oct;13(7):2169-2178. doi: 10.1016/j.nano.2017.05.012. Epub 2017 Jun 1.

PMID:
28579436
33.

Blockade of Neutrophil's Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure.

Khanam A, Trehanpati N, Riese P, Rastogi A, Guzman CA, Sarin SK.

Front Immunol. 2017 Apr 24;8:464. doi: 10.3389/fimmu.2017.00464. eCollection 2017.

34.

Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.

Rueckert C, Rand U, Roy U, Kasmapour B, Strowig T, Guzmán CA.

FASEB J. 2017 Jul;31(7):3107-3115. doi: 10.1096/fj.201601093R. Epub 2017 Apr 10.

PMID:
28396343
35.

Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population.

Akmatov MK, Riese P, May M, Jentsch L, Ahmed MW, Werner D, Rösel A, Tyler M, Pessler K, Prokein J, Bernemann I, Klopp N, Prochnow B, Trittel S, Tallam A, Illig T, Schindler C, Guzmán CA, Pessler F.

Hum Vaccin Immunother. 2017 Jul 3;13(7):1630-1639. doi: 10.1080/21645515.2017.1299300. Epub 2017 Apr 10.

36.

Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver.

Volckmar J, Gereke M, Ebensen T, Riese P, Philipsen L, Lienenklaus S, Wohlleber D, Klopfleisch R, Stegemann-Koniszewski S, Müller AJ, Gruber AD, Knolle P, Guzman CA, Bruder D.

Sci Rep. 2017 Mar 7;7:43985. doi: 10.1038/srep43985.

37.

Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.

Matos MN, Cazorla SI, Schulze K, Ebensen T, Guzmán CA, Malchiodi EL.

PLoS Negl Trop Dis. 2017 Feb 24;11(2):e0005300. doi: 10.1371/journal.pntd.0005300. eCollection 2017 Feb.

38.

Motivations for (non)participation in population-based health studies among the elderly - comparison of participants and nonparticipants of a prospective study on influenza vaccination.

Akmatov MK, Jentsch L, Riese P, May M, Ahmed MW, Werner D, Rösel A, Prokein J, Bernemann I, Klopp N, Prochnow B, Illig T, Schindler C, Guzman CA, Pessler F.

BMC Med Res Methodol. 2017 Feb 2;17(1):18. doi: 10.1186/s12874-017-0302-z.

39.

A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects.

Ziegler A, Soldner C, Lienenklaus S, Spanier J, Trittel S, Riese P, Kramps T, Weiss S, Heidenreich R, Jasny E, Guzmán CA, Kallen KJ, Fotin-Mleczek M, Kalinke U.

J Immunol. 2017 Feb 15;198(4):1595-1605. doi: 10.4049/jimmunol.1601129. Epub 2017 Jan 11.

40.

Self-Replicating RNA Vaccine Delivery to Dendritic Cells.

Démoulins T, Englezou PC, Milona P, Ruggli N, Tirelli N, Pichon C, Sapet C, Ebensen T, Guzmán CA, McCullough KC.

Methods Mol Biol. 2017;1499:37-75. Review.

PMID:
27987142
41.

Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.

Tomić A, Varanasi PR, Golemac M, Malić S, Riese P, Borst EM, Mischak-Weissinger E, Guzmán CA, Krmpotić A, Jonjić S, Messerle M.

PLoS Pathog. 2016 Dec 1;12(12):e1006015. doi: 10.1371/journal.ppat.1006015. eCollection 2016 Dec.

42.

The proneurotrophin receptor sortilin is required for Mycobacterium tuberculosis control by macrophages.

Vázquez CL, Rodgers A, Herbst S, Coade S, Gronow A, Guzman CA, Wilson MS, Kanzaki M, Nykjaer A, Gutierrez MG.

Sci Rep. 2016 Jul 8;6:29332. doi: 10.1038/srep29332.

43.

New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy.

Schulze K, Ebensen T, Riese P, Prochnow B, Lehr CM, Guzmán CA.

Curr Top Microbiol Immunol. 2016;398:207-234. doi: 10.1007/82_2016_495. Review.

PMID:
27370343
44.

Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions.

Börger AK, Eicke D, Wolf C, Gras C, Aufderbeck S, Schulze K, Engels L, Eiz-Vesper B, Schambach A, Guzman CA, Lachmann N, Moritz T, Martin U, Blasczyk R, Figueiredo C.

Mol Med. 2016 Sep;22:274-285. doi: 10.2119/molmed.2015.00235. Epub 2016 May 16.

45.

Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines.

Démoulins T, Milona P, Englezou PC, Ebensen T, Schulze K, Suter R, Pichon C, Midoux P, Guzmán CA, Ruggli N, McCullough KC.

Nanomedicine. 2016 Apr;12(3):711-722. doi: 10.1016/j.nano.2015.11.001. Epub 2015 Dec 1.

PMID:
26592962
46.

Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology.

Gordon S, Daneshian M, Bouwstra J, Caloni F, Constant S, Davies DE, Dandekar G, Guzman CA, Fabian E, Haltner E, Hartung T, Hasiwa N, Hayden P, Kandarova H, Khare S, Krug HF, Kneuer C, Leist M, Lian G, Marx U, Metzger M, Ott K, Prieto P, Roberts MS, Roggen EL, Tralau T, van den Braak C, Walles H, Lehr CM.

ALTEX. 2015;32(4):327-78. doi: 10.14573/altex.1510051.

47.

Modeling Influenza Virus Infection: A Roadmap for Influenza Research.

Boianelli A, Nguyen VK, Ebensen T, Schulze K, Wilk E, Sharma N, Stegemann-Koniszewski S, Bruder D, Toapanta FR, Guzmán CA, Meyer-Hermann M, Hernandez-Vargas EA.

Viruses. 2015 Oct 12;7(10):5274-304. doi: 10.3390/v7102875. Review.

48.

Rodents as pre-clinical models for predicting vaccine performance in humans.

Riese P, Trittel S, Schulze K, Guzmán CA.

Expert Rev Vaccines. 2015;14(9):1213-25. Review.

PMID:
26268433
49.

Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.

Perin PM, Haid S, Brown RJ, Doerrbecker J, Schulze K, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Baktash YM, Vondran FW, Speerstra S, Awadh A, Mukhtarov F, Schang LM, Kirschning A, Müller R, Guzman CA, Kaderali L, Randall G, Meuleman P, Ploss A, Pietschmann T.

Hepatology. 2016 Jan;63(1):49-62. doi: 10.1002/hep.28111. Epub 2015 Oct 9.

50.

Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements.

Kramer R, Sauer-Heilborn A, Welte T, Guzman CA, Abraham WR, Höfle MG.

J Clin Microbiol. 2015 Sep;53(9):2900-7. doi: 10.1128/JCM.01094-15. Epub 2015 Jul 1.

Supplemental Content

Loading ...
Support Center